Skip to main content
Fig. 3 | Human Genomics

Fig. 3

From: Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic–pharmacodynamic profiles of rivaroxaban

Fig. 3

ROC curve of 3 h miR-483 level and FC3h-0h in case and control healthy volunteers taken 15 mg rivaroxaban. A group classified by AXA3h; B group classified by AUC0-t. AXA3h, anti-Xa activity measured 3 h after rivaroxaban administration; AUC0-t: the area under the plasma concentration–time curve from time 0-t h; FC3h-0h: fold change between 3 and 0 h

Back to article page

Human Genomics

ISSN: 1479-7364